What the superinvestors bought and sold in 2024 Q3

134 of 137 filedholdings as of 30 Sep 2024as of today

2026 Q3 filings are coming in 0 of 137 filed · due 16 Nov See the early read

79 of 133 managers were net sellers. Setting price aside, they took $60.8B out, led by Information Technology (−$33.1B), while adding to Materials (+$2.2B). DIS was the most widely bought stock (10 bought, 3 sold); META the most widely sold (23 sold, 7 bought).

Net buyers 47 of 133 managers 79 sold more than they bought · 7 about even

Net bought −$60.8B Price moves taken out; prices alone moved the book +$93.2B.

Positions opened 626 673 closed out. IPOs, spin-offs and mergers left out.

Combined book, last quarter +6.9% SPY +5.4%, 1.5 pts ahead. Price only.

Most bought and sold

Ranked by net dollars bought or sold, with price moves taken out. Open a stock to see who.

Most bought

1 FLUT Flutter Entmt PLC 10 bought · 4 sold +$2.1B
Bought by
- Tom Bancroft - Makaira Partners opened 6.1% of book
- John Armitage - Egerton Capital (UK) added 1.9% → 4.3%
- William Von Mueffling - Cantillon Capital Management added 0.07% → 3.5%
- Chase Coleman - Tiger Global Management opened 3.4% of book
- Andreas Halvorsen - Viking Global Investors opened 2.2% of book
- Ryan Packard - Hiddenite Capital Partners opened 1.6% of book
- Dan Loeb - Third Point opened 1.6% of book
- Lee Ainslie - Maverick Capital added 0.09% → 1.0%
and 2 more
Sold by
- Stanley Druckenmiller - Duquesne Family Office cut 2.1% → 2.1%
- Dan Sundheim - D1 Capital Partners closed was 1.3%
- Valueact Capital - Valueact Holdings closed was 1.3%
- Farallon Capital Management cut 0.17% → 0.06%
FLUT: every holder and its history
2 SIRI Sirius Xm Holdings Inc. 6 bought · 0 sold +$2.1B
Bought by
- Wallace Weitz - Weitz Investment Management opened 1.5% of book
- Warren Buffett - Berkshire Hathaway added 0.13% → 0.93%
- Francis Chou - Chou Associates Management opened 0.35% of book
- Steven Check - Check Capital Management opened 0.12% of book
- Murray Stahl - Horizon Kinetics Asset Management opened 0.02% of book
- Lee Ainslie - Maverick Capital opened 0.02% of book
Sold by

No manager sold.

SIRI: every holder and its history
3 APD Air Products & Chemicals, Inc. 6 bought · 0 sold +$2.1B
Bought by
- Sachem Head Capital Management opened 8.6% of book
- Dodge & Cox added <0.01% → 1.1%
- Thomas Gayner - Markel Group added 0.10% → 0.14%
- Corvex Management opened 0.10% of book
- Jensen Investment Management added 0.02% → 0.03%
- Mairs & Power opened <0.01% of book
Sold by

No manager sold.

APD: every holder and its history
4 LUV Southwest Airls Co. 2 bought · 0 sold +$1.6B
Bought by
- Paul Singer - Elliott Investment Management added 0.99% → 9.4%
- Robert Olstein - Olstein Capital Management added 0.98% → 1.3%
Sold by

No manager sold.

LUV: every holder and its history
5 BN Brookfield Corp. 3 bought · 4 sold +$1.6B
Bought by
- Bill Ackman - Pershing Square added 2.7% → 13.5%
- Dan Loeb - Third Point opened 3.4% of book
- Ron Baron - Bamco Inc. (Baron Capital) added 0.15% → 0.27%
Sold by
- Josh Tarasoff - Greenlea Lane Capital Management cut 17.5% → 16.7%
- Eric Mandelblatt - Soroban Capital Partners cut 7.0% → 8.2%
- Third Avenue Management cut 3.5% → 4.0%
- Murray Stahl - Horizon Kinetics Asset Management cut 0.84% → 0.84%
BN: every holder and its history
6 ORCL Oracle Corp. 2 bought · 7 sold +$1.2B
Bought by
- Polen Capital Management opened 3.9% of book
- George Soros - Soros Fund Management opened 0.24% of book
Sold by
- David Tepper - Appaloosa cut 4.6% → 4.0%
- Harry Burn - Sound Shore Management cut 3.2% → 2.4%
- Sarah Ketterer - Causeway Capital Management cut 1.9% → 1.7%
- Don Yacktman - Yacktman Asset Management cut 1.2% → 1.1%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.55% → 0.38%
- John Rogers - Ariel Investments cut 0.09% → 0.10%
- Lee Ainslie - Maverick Capital closed was 0.05%
ORCL: every holder and its history
7 PDD Pdd Holdings Inc. 9 bought · 4 sold +$1.2B
Bought by
- David Tepper - Appaloosa added 4.2% → 10.6%
- Marc Stad - Dragoneer Investment Group added 6.7% → 8.8%
- Ram Parameswaran - Octahedron Capital Management opened 5.9% of book
- Duan Yongping - H&H International Investment added 0.08% → 3.2%
- Alex Sacerdote - Whale Rock Capital Management added 2.3% → 2.9%
- Philippe Laffont - Coatue Management added 0.16% → 1.3%
- Nehal Chopra - Ratan Capital Management opened 0.62% of book
- Howard Marks - Oaktree Capital Management opened 0.61% of book
and 1 more
Sold by
- Brad Gerstner - Altimeter Capital Management closed was 3.4%
- Dan Sundheim - D1 Capital Partners cut 1.0% → 1.00%
- Ron Baron - Bamco Inc. (Baron Capital) cut 0.27% → 0.07%
- Lee Ainslie - Maverick Capital closed was 0.01%
PDD: every holder and its history
8 DG Dollar Gen Corp. New 5 bought · 0 sold +$952M
Bought by
- Christopher Bloomstran - Semper Augustus Investments Group added 10.4% → 12.3%
- Estuary Capital Management added 10.6% → 7.8%
- Seth Klarman - Baupost Group opened 5.5% of book
- Richard Pzena - Pzena Investment Management added 0.86% → 2.8%
- Thomas Gayner - Markel Group added 0.91% → 0.56%
Sold by

No manager sold.

DG: every holder and its history
9 CEG Constellation Energy Corp. 3 bought · 2 sold +$931M
Bought by
- Philippe Laffont - Coatue Management added 3.8% → 7.5%
- Stephen Mandel - Lone Pine Capital added 2.6% → 4.6%
- Dan Sundheim - D1 Capital Partners opened 0.92% of book
Sold by
- Nehal Chopra - Ratan Capital Management closed was 6.1%
- Davidson Kempner Capital Management cut 0.54% → 0.16%
CEG: every holder and its history
10 SPOT Spotify Technology S A 3 bought · 5 sold +$767M
Bought by
- Andreas Halvorsen - Viking Global Investors added 0.57% → 3.5%
- Davidson Kempner Capital Management opened 1.4% of book
- Philippe Laffont - Coatue Management opened 1.0% of book
Sold by
- Valueact Capital - Valueact Holdings closed was 6.0%
- Stephen Mandel - Lone Pine Capital cut 4.3% → 4.3%
- Dan Sundheim - D1 Capital Partners cut 3.6% → 4.3%
- Cathie Wood - Ark Investment Management cut 0.40% → 0.37%
- Lee Ainslie - Maverick Capital closed was 0.01%
SPOT: every holder and its history

Not counted as buying: 143 IPOs, spin-offs and new listings.

Most sold

1 AAPL Apple Inc. 7 bought · 15 sold −$24.8B
Sold by
- Duan Yongping - H&H International Investment cut 81.0% → 74.3%
- Warren Buffett - Berkshire Hathaway cut 30.1% → 26.2%
- Jensen Investment Management cut 6.7% → 7.1%
- Li Lu - Himalaya Capital Management cut 6.2% → 3.0%
- Dan Loeb - Third Point cut 4.7% → 2.9%
- Glen Kacher - Light Street Capital Management cut 3.7% → 3.6%
- Alex Sacerdote - Whale Rock Capital Management closed was 1.6%
- Brad Gerstner - Altimeter Capital Management closed was 0.85%
and 7 more
Bought by
- Mala Gaonkar - Surgocap Partners added 5.9% → 8.3%
- Andreas Halvorsen - Viking Global Investors added 3.7% → 4.1%
- Polen Capital Management opened 4.1% of book
- Gavin Baker - Atreides Management added 2.2% → 2.5%
- John Armitage - Egerton Capital (UK) opened 0.47% of book
- Sarah Ketterer - Causeway Capital Management opened <0.01% of book
- Cathie Wood - Ark Investment Management opened <0.01% of book
AAPL: every holder and its history
2 BAC Bank Amer Corp. 3 bought · 6 sold −$8.9B
Sold by
- Warren Buffett - Berkshire Hathaway cut 14.7% → 11.9%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.8% → 1.8%
- Arnold Van Den Berg - Van Den Berg Management I cut 2.3% → 0.85%
- Dodge & Cox cut 1.4% → 1.2%
- Murphy Pohlad - Murphy Pohlad Asset Management cut 1.2% → 0.65%
- Duan Yongping - H&H International Investment closed was 0.03%
Bought by
- Dan Sundheim - D1 Capital Partners opened 3.4% of book
- Andreas Halvorsen - Viking Global Investors opened 2.9% of book
- Murray Stahl - Horizon Kinetics Asset Management added 0.02% → 0.03%
BAC: every holder and its history
3 MSFT Microsoft Corp. 12 bought · 19 sold −$4.1B
Sold by
- Gates Foundation Trust cut 32.7% → 27.6%
- Terry Smith - Fundsmith cut 13.0% → 11.7%
- Josh Tarasoff - Greenlea Lane Capital Management cut 10.9% → 5.1%
- Brad Gerstner - Altimeter Capital Management cut 10.8% → 10.1%
- Polen Capital Management cut 10.1% → 7.8%
- David Tepper - Appaloosa cut 8.6% → 6.2%
- Dan Loeb - Third Point cut 8.1% → 5.0%
- Jensen Investment Management cut 8.1% → 7.6%
and 11 more
Bought by
- Eric Mandelblatt - Soroban Capital Partners added 21.3% → 20.1%
- Triple Frond Partners added 12.0% → 14.0%
- Chris Hohn - Tci Fund Management added 11.5% → 11.7%
- Grant Wonders - Voyager Global Management added 5.0% → 8.4%
- Nehal Chopra - Ratan Capital Management added 5.2% → 7.9%
- John Armitage - Egerton Capital (UK) added 6.7% → 7.5%
- Ako Capital added 7.4% → 7.1%
- Farallon Capital Management added 2.5% → 3.1%
and 4 more
MSFT: every holder and its history
4 GOOG / GOOGL Alphabet 12 bought · 24 sold −$2.2B
Sold by
- Tweedy, Browne Co. cut 17.5% → 13.9%
- Altarock Partners cut 15.0% → 10.9%
- Ram Parameswaran - Octahedron Capital Management cut 14.3% → 2.7%
- First Pacific Advisors cut 13.0% → 10.7%
- Ruane, Cunniff & Goldfarb cut 12.1% → 10.7%
- Thomas Russo - Gardner Russo & Quinn cut 12.1% → 10.3%
- Polen Capital Management cut 8.6% → 6.1%
- Alex Sacerdote - Whale Rock Capital Management cut 7.7% → 5.6%
and 16 more
Bought by
- Grant Wonders - Voyager Global Management added 13.8% → 19.0%
- Triple Frond Partners added 15.5% → 18.1%
- Eric Mandelblatt - Soroban Capital Partners added 15.0% → 15.4%
- Seth Klarman - Baupost Group added 5.4% → 7.0%
- Corvex Management added 4.3% → 4.1%
- Philippe Laffont - Coatue Management added 2.4% → 2.7%
- Sarah Ketterer - Causeway Capital Management added 2.4% → 2.3%
- Farallon Capital Management added 1.6% → 2.0%
and 4 more
GOOG / GOOGL: every holder and its history
5 AMZN Amazon Com Inc. 14 bought · 16 sold −$2B
Sold by
- Josh Tarasoff - Greenlea Lane Capital Management cut 25.5% → 21.2%
- Polen Capital Management cut 14.4% → 12.4%
- Dan Loeb - Third Point cut 11.3% → 9.3%
- David Tepper - Appaloosa cut 10.9% → 8.9%
- Ram Parameswaran - Octahedron Capital Management cut 9.9% → 10.2%
- Chris James - Meritage Group cut 8.1% → 6.5%
- John Armitage - Egerton Capital (UK) cut 7.6% → 5.8%
- Vulcan Value Partners cut 7.4% → 7.1%
and 8 more
Bought by
- Altarock Partners added 16.4% → 19.8%
- Triple Frond Partners added 12.3% → 14.4%
- Grant Wonders - Voyager Global Management added 9.9% → 11.1%
- Philippe Laffont - Coatue Management added 8.1% → 7.8%
- Nehal Chopra - Ratan Capital Management added 6.7% → 7.8%
- Stephen Mandel - Lone Pine Capital added 7.0% → 7.6%
- Alex Sacerdote - Whale Rock Capital Management added 6.7% → 7.5%
- Lee Ainslie - Maverick Capital added 5.3% → 5.5%
and 6 more
AMZN: every holder and its history
6 CRM Salesforce Inc. 5 bought · 10 sold −$2B
Sold by
- Starboard Value cut 10.1% → 8.4%
- Vulcan Value Partners cut 5.8% → 6.4%
- Polen Capital Management cut 4.3% → 0.03%
- Glen Kacher - Light Street Capital Management cut 4.2% → 3.2%
- Farallon Capital Management cut 3.6% → 2.7%
- Ben Jacobs - Anomaly Capital Management closed was 2.1%
- Philippe Laffont - Coatue Management closed was 1.9%
- Davidson Kempner Capital Management cut 0.92% → 0.37%
and 2 more
Bought by
- Stephen Mandel - Lone Pine Capital opened 4.8% of book
- Brad Gerstner - Altimeter Capital Management added 1.4% → 1.9%
- Alex Sacerdote - Whale Rock Capital Management opened 0.87% of book
- George Soros - Soros Fund Management opened 0.62% of book
- Andreas Halvorsen - Viking Global Investors added 0.40% → 0.54%
CRM: every holder and its history
7 BRK.B / BRK.A Berkshire Hathaway 0 bought · 13 sold −$1.7B
Sold by
- Tweedy, Browne Co. cut 21.2% → 21.7%
- Gates Foundation Trust cut 21.0% → 22.6%
- Thomas Russo - Gardner Russo & Quinn cut 19.6% → 20.9%
- Steven Check - Check Capital Management cut 17.1% → 16.4%
- Duan Yongping - H&H International Investment cut 9.5% → 10.5%
- Christopher Davis - Davis Selected Advisers cut 8.4% → 8.2%
- Arnold Van Den Berg - Van Den Berg Management I cut 6.6% → 6.1%
- Torray Investment Partners cut 3.9% → 3.7%
and 5 more
Bought by

No manager bought.

BRK.B / BRK.A: every holder and its history
8 TFC Truist Financial Corp. 1 bought · 5 sold −$1.4B
Sold by
- Dodge & Cox cut 1.2% → 0.62%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.70% → 0.30%
- John Rogers - Ariel Investments closed was 0.42%
- First Eagle Investment Management cut <0.01% → <0.01%
- Thomas Russo - Gardner Russo & Quinn cut <0.01% → <0.01%
Bought by
- Stanley Druckenmiller - Duquesne Family Office opened 0.34% of book
TFC: every holder and its history
9 MPC Marathon Pete Corp. 0 bought · 1 sold −$1.2B
Sold by
- Paul Singer - Elliott Investment Management closed was 7.4%
Bought by

No manager bought.

MPC: every holder and its history
10 PM Philip Morris International 2 bought · 5 sold −$1.1B
Sold by
- Dan Sundheim - D1 Capital Partners cut 10.4% → 7.7%
- Terry Smith - Fundsmith cut 6.0% → 5.8%
- Stephen Mandel - Lone Pine Capital cut 5.5% → 4.1%
- Andreas Halvorsen - Viking Global Investors cut 4.2% → 4.0%
- John Rogers - Ariel Investments cut 0.35% → 0.22%
Bought by
- Stanley Druckenmiller - Duquesne Family Office added 3.1% → 4.7%
- Murray Stahl - Horizon Kinetics Asset Management added 0.04% → 0.07%
PM: every holder and its history

Not counted as selling: 141 mergers and delistings.

Ranked by dollars, single large books set the order: 3 of these 20 names were traded by one or two managers.

Opened and closed

New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.

Opened by the most managers

FLUT Flutter Entmt PLC 6 managers avg 2.6% of book · Tom Bancroft - Makaira Partners, Chase Coleman - Tiger Global Management and 4 more
Opened by
- Tom Bancroft - Makaira Partners opened 6.1% of book
- Chase Coleman - Tiger Global Management opened 3.4% of book
- Andreas Halvorsen - Viking Global Investors opened 2.2% of book
- Ryan Packard - Hiddenite Capital Partners opened 1.6% of book
- Dan Loeb - Third Point opened 1.6% of book
- Senator Investment Group opened 0.73% of book
FLUT: every holder and its history
TSM Taiwan Semiconductor Mfg Ltd 6 managers avg 2.4% of book · Estuary Capital Management, Nehal Chopra - Ratan Capital Management and 4 more
Opened by
- Estuary Capital Management opened 8.0% of book
- Nehal Chopra - Ratan Capital Management opened 2.4% of book
- Eric Mandelblatt - Soroban Capital Partners opened 2.3% of book
- Brad Gerstner - Altimeter Capital Management opened 1.3% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.34% of book
- Hillman Capital Management opened 0.10% of book
TSM: every holder and its history
SBUX Starbucks Corp. 6 managers avg 1.7% of book · Nehal Chopra - Ratan Capital Management, Stephen Mandel - Lone Pine Capital and 4 more
Opened by
- Nehal Chopra - Ratan Capital Management opened 3.3% of book
- Stephen Mandel - Lone Pine Capital opened 2.9% of book
- Dan Sundheim - D1 Capital Partners opened 2.2% of book
- Davidson Kempner Capital Management opened 1.1% of book
- Andreas Halvorsen - Viking Global Investors opened 0.59% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.17% of book
SBUX: every holder and its history
AVGO Broadcom Inc. 5 managers avg 1.4% of book · Nehal Chopra - Ratan Capital Management, Stanley Druckenmiller - Duquesne Family Office and 3 more
Opened by
- Nehal Chopra - Ratan Capital Management opened 3.1% of book
- Stanley Druckenmiller - Duquesne Family Office opened 1.4% of book
- Lee Ainslie - Maverick Capital opened 1.2% of book
- Brad Gerstner - Altimeter Capital Management opened 1.0% of book
- Davidson Kempner Capital Management opened 0.35% of book
AVGO: every holder and its history
SIRI Sirius Xm Holdings Inc. 5 managers avg 0.40% of book · Wallace Weitz - Weitz Investment Management, Francis Chou - Chou Associates Management and 3 more
Opened by
- Wallace Weitz - Weitz Investment Management opened 1.5% of book
- Francis Chou - Chou Associates Management opened 0.35% of book
- Steven Check - Check Capital Management opened 0.12% of book
- Murray Stahl - Horizon Kinetics Asset Management opened 0.02% of book
- Lee Ainslie - Maverick Capital opened 0.02% of book
SIRI: every holder and its history
ADSK Autodesk Inc. 4 managers avg 3.0% of book · Starboard Value, Andreas Halvorsen - Viking Global Investors and 2 more
Opened by
- Starboard Value opened 10.8% of book
- Andreas Halvorsen - Viking Global Investors opened 0.77% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.34% of book
- Mairs & Power opened <0.01% of book
ADSK: every holder and its history
GTLB Gitlab Inc. 4 managers avg 1.5% of book · Glen Kacher - Light Street Capital Management, Ryan Packard - Hiddenite Capital Partners and 2 more
Opened by
- Glen Kacher - Light Street Capital Management opened 4.5% of book
- Ryan Packard - Hiddenite Capital Partners opened 0.84% of book
- Gavin Baker - Atreides Management opened 0.65% of book
- Cathie Wood - Ark Investment Management opened 0.12% of book
GTLB: every holder and its history
AAPL Apple Inc. 4 managers avg 1.1% of book · Polen Capital Management, John Armitage - Egerton Capital (UK) and 2 more
Opened by
- Polen Capital Management opened 4.1% of book
- John Armitage - Egerton Capital (UK) opened 0.47% of book
- Sarah Ketterer - Causeway Capital Management opened <0.01% of book
- Cathie Wood - Ark Investment Management opened <0.01% of book
AAPL: every holder and its history
TSLA Tesla Inc. 4 managers avg 1.1% of book · Brad Gerstner - Altimeter Capital Management, Dan Loeb - Third Point and 2 more
Opened by
- Brad Gerstner - Altimeter Capital Management opened 2.6% of book
- Dan Loeb - Third Point opened 1.4% of book
- Andreas Halvorsen - Viking Global Investors opened 0.42% of book
- David Katz - Matrix Asset Advisors opened 0.02% of book
TSLA: every holder and its history
BNTX Biontech Se 4 managers avg 0.38% of book · David Witzke - Avidity Partners Management, Palo Alto Investors and 2 more
Opened by
- David Witzke - Avidity Partners Management opened 0.88% of book
- Palo Alto Investors opened 0.39% of book
- Nathan Fischel - Dafna Capital Management opened 0.24% of book
- Andreas Halvorsen - Viking Global Investors opened 0.02% of book
BNTX: every holder and its history

Closed out by the most managers

META Meta Platforms Inc. 7 managers was avg 0.91% of book · Lee Ainslie - Maverick Capital, Gavin Baker - Atreides Management and 5 more
Closed by
- Lee Ainslie - Maverick Capital closed was 2.8%
- Gavin Baker - Atreides Management closed was 1.4%
- Grant Wonders - Voyager Global Management closed was 1.1%
- Prem Watsa - Fairfax Financial Holdings closed was 0.55%
- Andreas Halvorsen - Viking Global Investors closed was 0.52%
- Chris James - Meritage Group closed was <0.01%
- Polen Capital Management closed was <0.01%
META: every holder and its history
MU Micron Technology Inc. 7 managers was avg 0.76% of book · Ben Hoskin - Value Aligned Research Advisors, Alex Sacerdote - Whale Rock Capital Management and 5 more
Closed by
- Ben Hoskin - Value Aligned Research Advisors closed was 3.7%
- Alex Sacerdote - Whale Rock Capital Management closed was 0.83%
- Dan Loeb - Third Point closed was 0.41%
- Spencer Waxman - Shannon River Fund Management closed was 0.22%
- George Soros - Soros Fund Management closed was 0.07%
- Don Yacktman - Yacktman Asset Management closed was 0.04%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
MU: every holder and its history
AAPL Apple Inc. 5 managers was avg 0.71% of book · Alex Sacerdote - Whale Rock Capital Management, Brad Gerstner - Altimeter Capital Management and 3 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 1.6%
- Brad Gerstner - Altimeter Capital Management closed was 0.85%
- Davidson Kempner Capital Management closed was 0.52%
- George Soros - Soros Fund Management closed was 0.38%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.18%
AAPL: every holder and its history
NVDA Nvidia Corporation 4 managers was avg 3.9% of book · Spencer Waxman - Shannon River Fund Management, Mala Gaonkar - Surgocap Partners and 2 more
Closed by
- Spencer Waxman - Shannon River Fund Management closed was 8.2%
- Mala Gaonkar - Surgocap Partners closed was 6.2%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.91%
- Ram Parameswaran - Octahedron Capital Management closed was 0.43%
NVDA: every holder and its history
DELL Dell Technologies Inc. 4 managers was avg 3.0% of book · Nehal Chopra - Ratan Capital Management, Glen Kacher - Light Street Capital Management and 2 more
Closed by
- Nehal Chopra - Ratan Capital Management closed was 6.0%
- Glen Kacher - Light Street Capital Management closed was 4.0%
- Ben Jacobs - Anomaly Capital Management closed was 1.0%
- Brad Gerstner - Altimeter Capital Management closed was 1.0%
DELL: every holder and its history
QCOM Qualcomm Inc. 4 managers was avg 2.3% of book · Mala Gaonkar - Surgocap Partners, Alex Sacerdote - Whale Rock Capital Management and 2 more
Closed by
- Mala Gaonkar - Surgocap Partners closed was 7.3%
- Alex Sacerdote - Whale Rock Capital Management closed was 1.9%
- Glen Kacher - Light Street Capital Management closed was 0.07%
- Lee Ainslie - Maverick Capital closed was 0.03%
QCOM: every holder and its history
MRVL Marvell Technology Inc. 4 managers was avg 2.0% of book · Gavin Baker - Atreides Management, Dan Sundheim - D1 Capital Partners and 2 more
Closed by
- Gavin Baker - Atreides Management closed was 5.8%
- Dan Sundheim - D1 Capital Partners closed was 1.8%
- Nehal Chopra - Ratan Capital Management closed was 0.42%
- Ron Baron - Bamco Inc. (Baron Capital) closed was 0.04%
MRVL: every holder and its history
AVGO Broadcom Inc. 4 managers was avg 1.5% of book · Muhlenkamp & Co., Andreas Halvorsen - Viking Global Investors and 2 more
Closed by
- Muhlenkamp & Co. closed was 4.1%
- Andreas Halvorsen - Viking Global Investors closed was 1.8%
- Spencer Waxman - Shannon River Fund Management closed was 0.18%
- George Soros - Soros Fund Management closed was 0.01%
AVGO: every holder and its history
INTC Intel Corp. 4 managers was avg 1.4% of book · Estuary Capital Management, James Silverman - Opaleye Management and 2 more
Closed by
- Estuary Capital Management closed was 4.3%
- James Silverman - Opaleye Management closed was 1.1%
- David Witzke - Avidity Partners Management closed was 0.16%
- Richard Pzena - Pzena Investment Management closed was <0.01%
INTC: every holder and its history
APH Amphenol Corp. 4 managers was avg 1.2% of book · Brad Gerstner - Altimeter Capital Management, Philippe Laffont - Coatue Management and 2 more
Closed by
- Brad Gerstner - Altimeter Capital Management closed was 2.0%
- Philippe Laffont - Coatue Management closed was 1.6%
- Lee Ainslie - Maverick Capital closed was 1.2%
- David Katz - Matrix Asset Advisors closed was 0.02%
APH: every holder and its history

Where the money went

Net bought by sector, with price moves taken out. Pick a sector to see its names.

Industrials gained weight (+0.7 pts) even though managers sold $871M of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): −$716M.

Who moved the most

The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.

Biggest new bets

King Street Capital Management opened SGRY · Surgery Partners Inc. 31.8% of book
Jana Partners Management opened LW · Lamb Weston Hldgs Inc. 11.9% of book
Starboard Value opened ADSK · Autodesk Inc. 10.8% of book
Pat Dorsey - Dorsey Asset Management opened APP · Applovin Corp. 9.8% of book
Mala Gaonkar - Surgocap Partners opened META · Meta Platforms Inc. 8.7% of book
Sachem Head Capital Management opened APD · Air Products & Chemicals, Inc. 8.6% of book

Most active managers

Estuary Capital Management 6 opened · 6 closed · +$111M net 87% of book traded
Dan Sundheim - D1 Capital Partners 10 opened · 12 closed · −$1.6B net 77% of book traded
Stanley Druckenmiller - Duquesne Family Office 30 opened · 21 closed · −$361M net 70% of book traded
Gavin Baker - Atreides Management 6 opened · 11 closed · −$229M net 69% of book traded
Alex Roepers - Atlantic Investment Management 0 opened · 5 closed · −$5M net 69% of book traded
Andreas Halvorsen - Viking Global Investors 21 opened · 19 closed · −$29M net 67% of book traded

What they hold

Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, by dollars, so the biggest books lead it. Highest conviction is the average position among holders, three or more.

Most owned

1 GOOG / GOOGL Alphabet 68 managers −3
2 MSFT Microsoft Corp. 60 managers −1
3 AMZN Amazon Com Inc. 47 managers no change
4 META Meta Platforms Inc. 41 managers −4
5 BRK.B / BRK.A Berkshire Hathaway 36 managers −1
6 AAPL Apple Inc. 34 managers −1
7 V Visa Inc. 33 managers +3
8 TSM Taiwan Semiconductor Mfg Ltd 30 managers +3
9 MA Mastercard Inc. 28 managers no change
10 UNH Unitedhealth Group Inc. 27 managers −2

Largest

1 AAPL Apple Inc. 6.4% held by 34
2 MSFT Microsoft Corp. 3.5% held by 60
3 AXP American Express Co. 3.0% held by 16
4 GOOG / GOOGL Alphabet 3.0% held by 68
5 BAC Bank Amer Corp. 2.7% held by 22
6 META Meta Platforms Inc. 2.1% held by 41
7 KO Coca Cola Co. 2.0% held by 11
8 AMZN Amazon Com Inc. 1.8% held by 47
9 MCO Moodys Corp. 1.5% held by 19
10 BRK.B / BRK.A Berkshire Hathaway 1.5% held by 36

Highest conviction

1 CVNA Carvana Co. avg 21.4% held by 9
2 HOOD Robinhood Markets Inc. avg 17.9% held by 3
3 LOAR Loar Holdings Inc. avg 15.4% held by 3
4 CEIXEUR Consol Energy Inc. New avg 13.3% held by 3
5 BRK.B / BRK.A Berkshire Hathaway avg 10.6% held by 36
6 TDG Transdigm Group Inc. avg 9.9% held by 7
7 SNX Td Synnex Corporation avg 9.6% held by 5
8 UTHR United Therapeutics Corp. avg 9.6% held by 3
9 FICO Fair Isaac Corp. avg 9.2% held by 6
10 LBTYK Liberty Global Ltd avg 9.2% held by 3

See all 2,411 names

Did the combined book beat SPY?

Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.

Combined book, 8 quarters +33.3% SPY +37.2% Difference −3.9 pts

2024 Q2, the start +0.0% Combined book +0.0% SPY 2024 Q3, since 2024 Q2 +6.9% Combined book +5.4% SPY That quarter: book +6.9%, SPY +5.4% 2024 Q4, since 2024 Q2 +8.1% Combined book +7.7% SPY That quarter: book +1.1%, SPY +2.1% 2025 Q1, since 2024 Q2 +6.0% Combined book +2.8% SPY That quarter: book −2.0%, SPY −4.6% 2025 Q2, since 2024 Q2 +14.5% Combined book +13.5% SPY That quarter: book +8.0%, SPY +10.5% 2025 Q3, since 2024 Q2 +21.7% Combined book +22.4% SPY That quarter: book +6.3%, SPY +7.8% 2025 Q4, since 2024 Q2 +24.9% Combined book +25.3% SPY That quarter: book +2.6%, SPY +2.4% 2026 Q1, since 2024 Q2 +19.6% Combined book +19.5% SPY That quarter: book −4.2%, SPY −4.6% 2026 Q2, since 2024 Q2 +33.3% Combined book +37.2% SPY That quarter: book +11.5%, SPY +14.8%

Quarter by quarter

Quarter	Each manager once	By dollars	SPY	Book − SPY	Managers
2026 Q2	+14.5%	+11.5%	+14.8%	−3.4 pts	133
2026 Q1	−4.4%	−4.2%	−4.6%	+0.4 pts	136
2025 Q4	+2.1%	+2.6%	+2.4%	+0.2 pts	136
2025 Q3	+9.1%	+6.3%	+7.8%	−1.5 pts	136
2025 Q2	+11.6%	+8.0%	+10.5%	−2.4 pts	136
2025 Q1	−3.8%	−2.0%	−4.6%	+2.6 pts	136
2024 Q4	+2.6%	+1.1%	+2.1%	−1.0 pts	134
2024 Q3	+7.5%	+6.9%	+5.4%	+1.5 pts	133

All 2,411 names

Download CSV

Showing 300 of 347 matching names. The CSV has every name.

Ticker	Company	Sector	Held by	Weight, $	Net bought	Bought / sold	Opened / closed
UNH	Unitedhealth Group Inc.	Health Care	27 −2	0.79%	−$1B	5 / 14	2 / 4
DHR	Danaher Corporation	Health Care	16	0.10%	−$86M	3 / 6	1 / 1
JNJ	Johnson & Johnson	Health Care	16 +1	0.08%	−$8M	4 / 3	1 / 0
TMO	Thermo Fisher Scientific Inc.	Health Care	15 +1	0.22%	−$298M	2 / 6	1 / 0
CVS	Cvs Health Corp.	Health Care	14	0.45%	+$497M	5 / 4	1 / 1
MRK	Merck & Co. Inc.	Health Care	13 −2	0.04%	+$294M	2 / 5	1 / 3
ELV	Elevance Health Inc.	Health Care	12 −2	0.39%	−$151M	2 / 4	0 / 2
LLY	Eli Lilly & Co.	Health Care	12 +2	0.14%	+$42M	5 / 1	2 / 0
BMY	Bristol-Myers Squibb Co.	Health Care	12 +1	0.12%	−$2M	3 / 2	1 / 0
HCA	Hca Healthcare Inc.	Health Care	11	0.53%	+$47M	3 / 4	1 / 1
PFE	Pfizer Inc.	Health Care	11 −1	0.03%	−$216M	3 / 2	0 / 1
MDT	Medtronic PLC	Health Care	10	0.19%	−$1B	2 / 2	0 / 0
ABBV	Abbvie Inc.	Health Care	10 −1	0.01%	−$44M	1 / 4	0 / 1
CI	The Cigna Group	Health Care	9 −2	0.51%	−$191M	2 / 4	0 / 2
GEHC	Ge Healthcare Technologies, Inc.	Health Care	9	0.19%	+$131M	3 / 5	1 / 1
ZTS	Zoetis Inc.	Health Care	9 +1	0.16%	−$90M	2 / 2	1 / 0
ABT	Abbott Labs	Health Care	9 +1	0.13%	−$170M	1 / 2	1 / 0
THC	Tenet Healthcare Corp.	Health Care	9	0.05%	−$410M	1 / 4	0 / 0
TEVA	Teva Pharmaceutical Inds Ltd	Health Care	9 +1	0.03%	+$103M	3 / 4	2 / 1
HUM	Humana, Inc.	Health Care	8 −3	0.25%	+$53M	3 / 5	1 / 4
BAX	Baxter International, Inc.	Health Care	8	0.23%	+$680M	1 / 2	0 / 0
ZBH	Zimmer Biomet Holdings, Inc.	Health Care	8	0.14%	+$53M	2 / 1	0 / 0
NVO	Novo-Nordisk A S	Health Care	8 −2	0.09%	−$64M	1 / 5	0 / 2
WST	Western Alliance Bancorp	Health Care	8 +1	0.06%	−$53M	1 / 3	1 / 0
BSX	Boston Scientific Corp.	Health Care	8 +1	0.05%	+$174M	3 / 2	1 / 0
ILMN	Illumina Inc.	Health Care	8 +1	0.04%	+$3M	2 / 2	1 / 0
AMGN	Amgen Inc.	Health Care	8	<0.01%	−$59M	1 / 2	0 / 0
SNY	Sanofi SA	Health Care	7	0.32%	−$51M	3 / 2	1 / 1
REGN	Regeneron Pharmaceuticals, Inc.	Health Care	7 +1	0.18%	−$6M	2 / 3	2 / 1
NTRA	Natera Inc.	Health Care	7 −1	0.10%	+$243M	3 / 3	0 / 1
SOLV	Solventum Corporation	Health Care	7 −1	0.07%	+$123M	1 / 3	0 / 1
BDX	Becton Dickinson & Co.	Health Care	7	0.06%	+$140M	3 / 0	0 / 0
CAH	Cardinal Health Inc.	Health Care	7 −1	0.02%	−$87M	1 / 3	0 / 1
EW	Edwards Lifesciences Corp.	Health Care	7 +4	<0.01%	+$22M	4 / 1	4 / 0
GSK	Gsk PLC	Health Care	6	0.20%	−$11M	2 / 1	0 / 0
AVTR	Avantor, Inc.	Health Care	6 −1	0.15%	+$70M	2 / 3	0 / 1
VTRS	Viatris Inc.	Health Care	6 +1	0.06%	+$70M	3 / 0	1 / 0
ISRG	Intuitive Surgical Inc.	Health Care	6 −2	0.05%	−$199M	1 / 4	0 / 2
OSCR	Oscar Health Inc.	Health Care	6 +1	0.03%	−$58M	1 / 2	1 / 0
DGX	Quest Diagnostics Inc.	Health Care	6	0.03%	−$21M	2 / 3	0 / 0
INSM	Insmed Inc.	Health Care	6	0.02%	−$116M	2 / 3	1 / 1
BNTX	Biontech Se	Health Care	6 +4	<0.01%	+$23M	5 / 1	4 / 0
IQV	Iqvia Hldgs Inc.	Health Care	5 −1	0.25%	−$86M	1 / 2	0 / 1
SYK	Stryker Corp.	Health Care	5	0.18%	−$50M	1 / 1	0 / 0
CNC	Centene Corp. Del	Health Care	5 −1	0.16%	−$126M	1 / 2	0 / 1
BMRN	Biomarin Pharmaceutical, Inc.	Health Care	5 −1	0.14%	+$194M	2 / 3	1 / 2
NVS	Novartis AG	Health Care	5 −1	0.10%	−$26M	0 / 2	0 / 1
A	Agilent Technologies Inc.	Health Care	5 −1	0.06%	−$239M	0 / 3	0 / 1
TECH	Bio Techne Corp.	Health Care	5	0.04%	−$30M	2 / 2	0 / 0
BHC	Bausch Health Companies Inc.	Health Care	5 −1	0.04%	−$10M	1 / 1	0 / 1
CRL	Charles Riv Labs Intl Inc.	Health Care	5	0.03%	−$11M	0 / 2	0 / 0
VEEV	Veeva Sys Inc.	Health Care	5 −2	0.03%	+$3M	2 / 3	0 / 2
FTRE	Fortrea Hldgs Inc.	Health Care	5 +1	0.02%	+$30M	3 / 2	2 / 1
PCVX	Vaxcyte Inc.	Health Care	5 +1	<0.01%	−$21M	3 / 2	2 / 1
VRTX	Vertex Pharmaceuticals Inc.	Health Care	5 +1	<0.01%	+$47M	2 / 1	1 / 0
BIIB	Biogen Inc.	Health Care	5	<0.01%	−$14M	0 / 2	0 / 0
IMVT	Immunovant Inc.	Health Care	5 −1	<0.01%	−$31M	1 / 3	0 / 1
ALGN	Align Technology Inc.	Health Care	5	<0.01%	−$1M	3 / 1	0 / 0
GILD	Gilead Sciences, Inc.	Health Care	4 −1	0.20%	−$39M	0 / 3	0 / 1
IDXX	Idexx Laboratories Inc.	Health Care	4	0.16%	−$55M	1 / 1	0 / 0
UHS	Universal Hlth Svcs Inc.	Health Care	4	0.09%	−$116M	1 / 3	1 / 1
INCY	Incyte Corp.	Health Care	4 +1	0.08%	+$13M	1 / 2	1 / 0
ICLR	Icon PLC	Health Care	4	0.05%	−$3M	1 / 0	0 / 0
BIO	Bio Rad Labs Inc.	Health Care	4 −1	0.04%	+$114M	2 / 1	0 / 1
MCK	Mckesson Corp.	Health Care	4 −3	0.03%	−$290M	1 / 3	0 / 3
ACHC	Acadia Healthcare Company In	Health Care	4	0.03%	+$17M	1 / 2	0 / 0
RPRX	Royalty Pharma PLC	Health Care	4	0.03%	+$26M	2 / 0	0 / 0
NBIX	Neurocrine Biosciences, Inc.	Health Care	4	0.02%	−$8M	0 / 2	0 / 0
BHVN	Biohaven Ltd	Health Care	4	0.02%	+$69M	2 / 1	0 / 0
NAMS	Newamsterdam Pharma Company	Health Care	4 +1	0.01%	+$11M	3 / 0	1 / 0
RCKT	Rocket Pharmaceuticals Inc.	Health Care	4	<0.01%	−$5M	1 / 2	0 / 0
MEDP	Medpace Holdings Inc.	Health Care	4	<0.01%	+$15M	2 / 1	0 / 0
HSIC	Henry Schein Inc.	Health Care	4 +2	<0.01%	+$14M	3 / 0	2 / 0
HOLX	Hologic, Inc.	Health Care	4 +1	<0.01%	−$12M	1 / 2	1 / 0
SGRY	Surgery Partners Inc.	Health Care	4	<0.01%	−$65M	1 / 4	1 / 1
ASND	Ascendis Pharma A/S	Health Care	4 +2	<0.01%	+$44M	4 / 1	3 / 1
SNDX	Syndax Pharmaceuticals Inc.	Health Care	4	<0.01%	−$19M	0 / 2	0 / 0
RARE	Ultragenyx Pharmaceutical In	Health Care	4 +2	<0.01%	−$9M	2 / 2	2 / 0
CYTK	Cytokinetics Inc.	Health Care	4 −1	<0.01%	−$8M	1 / 2	0 / 1
ALKS	Alkermes PLC	Health Care	4	<0.01%	−$3M	0 / 1	0 / 0
URGN	Urogen Pharma Ltd	Health Care	4	<0.01%	−$611K	0 / 1	0 / 0
BCYC	Bicycle Therapeutics PLC	Health Care	4 +1	<0.01%	+$1M	1 / 0	1 / 0
DVA	Davita Inc.	Health Care	3 −1	0.42%	−$19M	1 / 2	0 / 1
WAT	Waters Corp.	Health Care	3	0.11%	−$35M	0 / 1	0 / 0
MTD	Mettler Toledo Ord	Health Care	3	0.09%	−$8M	0 / 0	0 / 0
ELAN	Elanco Animal Health, Inc.	Health Care	3 +1	0.09%	−$1M	2 / 0	1 / 0
ALNY	Alnylam Pharmaceuticals, Inc.	Health Care	3 −1	0.07%	−$110M	0 / 2	0 / 1
EXEL	Exelixis Inc.	Health Care	3	0.05%	−$54M	1 / 2	0 / 0
ROIV	Roivant Sciences Ltd	Health Care	3	0.05%	−$175M	1 / 2	0 / 0
RVMD	Revolution Medicines Inc.	Health Care	3 −1	0.04%	+$72M	1 / 1	0 / 1
NVST	Envista Holdings Corporation	Health Care	3	0.03%	+$23M	1 / 0	0 / 0
BEAM	Beam Therapeutics Inc.	Health Care	3	0.03%	−$20M	0 / 1	0 / 0
PRVA	Privia Health Group Inc.	Health Care	3 −1	0.02%	+$27M	2 / 2	0 / 1
Masimo	Masimo Corp.	Health Care	3 −1	0.02%	+$5M	1 / 1	0 / 1
PBH	Prestige Consmr Healthcare I	Health Care	3	0.01%	−$5M	0 / 1	0 / 0
IONS	Ionis Pharmaceuticals Inc.	Health Care	3 −2	0.01%	−$3M	0 / 2	0 / 2
SHC	Sotera Health Co.	Health Care	3 −2	0.01%	−$17M	0 / 2	0 / 2
CDNA	Caredx Inc.	Health Care	3	0.01%	−$96M	0 / 2	0 / 0
LH	Labcorp Holdings Inc.	Health Care	3	0.01%	−$8M	0 / 1	0 / 0
NVAX	Novavax Inc.	Health Care	3	0.01%	−$8M	1 / 2	0 / 0
COO	Cooper Cos Inc.	Health Care	3 +1	<0.01%	+$19M	1 / 0	1 / 0
UTHR	United Therapeutics Corp.	Health Care	3 −2	<0.01%	−$127M	0 / 5	0 / 2
JAZZ	Jazz Pharmaceuticals PLC	Health Care	3 −1	<0.01%	−$155M	0 / 2	0 / 1
OPCH	Option Care Health Inc.	Health Care	3	<0.01%	+$17M	2 / 2	1 / 1
BLCO	Bausch Plus Lomb Corp.	Health Care	3 +1	<0.01%	+$14M	1 / 0	1 / 0
VKTX	Viking Therapeutics Inc.	Health Care	3	<0.01%	−$46M	0 / 3	0 / 0
CRNX	Crinetics Pharmaceuticals In	Health Care	3	<0.01%	+$34M	1 / 0	0 / 0
CNTA	Centessa Pharmaceuticals PLC	Health Care	3 +1	<0.01%	+$47M	2 / 0	1 / 0
NRIX	Nurix Therapeutics Inc.	Health Care	3 −1	<0.01%	−$5M	0 / 1	0 / 1
EWTX	Edgewise Therapeutics Inc.	Health Care	3	<0.01%	−$3M	0 / 2	0 / 0
DXCM	Dexcom Inc.	Health Care	3 −3	<0.01%	−$118M	0 / 5	0 / 3
GKOS	Glaukos Corp.	Health Care	3	<0.01%	+$16M	1 / 0	0 / 0
XENE	Xenon Pharmaceuticals Inc.	Health Care	3	<0.01%	+$3M	1 / 0	0 / 0
DNA	Ginkgo Bioworks Holdings Inc. IPO or spin-off	Health Care	3 +3	<0.01%	+$40M	3 / 0	3 / 0
GRFS	Grifols S A	Health Care	3	<0.01%	−$3M	0 / 1	0 / 0
DYN	Dyne Therapeutics Inc.	Health Care	3 +1	<0.01%	+$21M	2 / 0	1 / 0
AXSM	Axsome Therapeutics Inc.	Health Care	3	<0.01%	−$7M	0 / 1	0 / 0
PRME	Prime Medicine Inc.	Health Care	3	<0.01%	−$2M	0 / 1	0 / 0
TALK	Talkspace Inc.	Health Care	3 +1	<0.01%	+$545K	1 / 0	1 / 0
NUVB	Nuvation Bio Inc.	Health Care	3	<0.01%	$0	0 / 0	0 / 0
RLMD	Relmada Therapeutics Inc.	Health Care	3	<0.01%	−$389K	0 / 1	0 / 0
Compugen	Compugen Ltd	Health Care	3	<0.01%	−$15K	0 / 0	0 / 0
BBIO	Bridgebio Pharma Inc.	Health Care	2 +1	0.05%	+$44M	1 / 0	1 / 0
ALC	Alcon Inc.	Health Care	2 +1	0.04%	−$14M	1 / 1	1 / 0
FMS	Fresenius Medical Care AG	Health Care	2	0.03%	−$387K	0 / 0	0 / 0
MDGL	Madrigal Pharmaceuticals Inc.	Health Care	2	0.03%	+$37M	1 / 0	0 / 0
XRAY	Dentsply Sirona Inc.	Health Care	2	0.03%	+$29M	1 / 0	0 / 0
CRSP	Crispr Therapeutics AG	Health Care	2 −1	0.02%	−$38M	0 / 1	0 / 1
LNTH	Lantheus Hldgs Inc.	Health Care	2 −1	0.02%	+$41M	1 / 2	0 / 1
PTGX	Protagonist Therapeutics Inc.	Health Care	2	0.02%	+$910K	0 / 0	0 / 0
TWST	Twist Bioscience Corp.	Health Care	2	0.02%	−$28M	1 / 1	0 / 0
ADPT	Adaptive Biotechnologies Cor	Health Care	2	0.01%	+$968K	0 / 0	0 / 0
VCYT	Veracyte Inc.	Health Care	2 −1	0.01%	−$73M	0 / 2	0 / 1
ITGR	Integer Hldgs Corp.	Health Care	2	0.01%	+$5M	1 / 0	0 / 0
SDGR	Schrodinger Inc.	Health Care	2	0.01%	−$2M	0 / 0	0 / 0
ARGX	Argenx Se	Health Care	2	0.01%	−$18M	0 / 1	0 / 0
OGN	Organon & Company	Health Care	2	<0.01%	+$9M	2 / 0	0 / 0
NEOG	Neogen Corp.	Health Care	2	<0.01%	+$3M	1 / 0	0 / 0
INDV	Indivior PLC	Health Care	2 +1	<0.01%	+$57M	2 / 0	1 / 0
ZLAB	Zai Lab Ltd	Health Care	2	<0.01%	+$638K	1 / 0	0 / 0
FOLD	Amicus Therapeutics Inc.	Health Care	2	<0.01%	−$9M	0 / 1	0 / 0
INSP	Inspire Med Sys Inc.	Health Care	2	<0.01%	−$2M	0 / 0	0 / 0
MRNA	Moderna Inc.	Health Care	2 −1	<0.01%	+$4M	1 / 2	0 / 1
LFST	Lifestance Health Group Inc.	Health Care	2 +1	<0.01%	−$12M	1 / 1	1 / 0
Perrigo	Perrigo Company PLC	Health Care	2	<0.01%	+$7M	2 / 0	0 / 0
ARVN	Arvinas Inc.	Health Care	2	<0.01%	−$19M	1 / 1	0 / 0
HQY	Healthequity Inc.	Health Care	2	<0.01%	−$4M	0 / 1	0 / 0
BTI	British Amern Tob PLC	Health Care	2	<0.01%	+$4M	1 / 0	0 / 0
IDYA	Ideaya Biosciences Inc.	Health Care	2	<0.01%	+$10M	2 / 0	0 / 0
ORIC	Oric Pharmaceuticals Inc.	Health Care	2	<0.01%	+$14M	1 / 1	1 / 1
LQDA	Liquidia Corporation	Health Care	2	<0.01%	+$26M	2 / 0	0 / 0
CATX	Perspective Therapeutics Inc.	Health Care	2	<0.01%	+$5M	1 / 0	0 / 0
IART	Integra Lifesciences Hldgs C	Health Care	2 +1	<0.01%	+$45M	2 / 0	1 / 0
PHG	Koninklijke Philips NV	Health Care	2	<0.01%	−$865K	0 / 1	0 / 0
EMBC	Embecta Corp.	Health Care	2	<0.01%	−$4M	0 / 1	0 / 0
ENTA	Enanta Pharmaceuticals Inc.	Health Care	2	<0.01%	+$3M	1 / 0	0 / 0
ANAB	Anaptysbio Inc.	Health Care	2 +1	<0.01%	+$8M	2 / 0	1 / 0
BFLY	Butterfly Network Inc.	Health Care	2	<0.01%	−$685K	1 / 1	0 / 0
ALVO	Alvotech SA	Health Care	2 +1	<0.01%	+$2M	1 / 0	1 / 0
MIRM	Mirum Pharmaceuticals Inc.	Health Care	2	<0.01%	$0	0 / 0	0 / 0
RGEN	Repligen Corp.	Health Care	2	<0.01%	+$2M	1 / 0	0 / 0
IOVA	Iovance Biotherapeutics Inc.	Health Care	2 −1	<0.01%	+$266K	1 / 1	0 / 1
ESTA	Establishment Labs Hldgs Inc.	Health Care	2	<0.01%	−$13M	1 / 1	0 / 0
LXEO	Lexeo Therapeutics Inc.	Health Care	2 +1	<0.01%	+$2M	1 / 0	1 / 0
BKD	Brookdale Sr Living Inc.	Health Care	2	<0.01%	−$30M	1 / 1	0 / 0
KYMR	Kymera Therapeutics Inc. IPO or spin-off	Health Care	2 +2	<0.01%	+$25M	2 / 0	2 / 0
TRVI	Trevi Therapeutics Inc.	Health Care	2	<0.01%	−$257K	0 / 0	0 / 0
NUVL	Nuvalent Inc.	Health Care	2 +1	<0.01%	+$16M	2 / 0	1 / 0
PGNY	Progyny Inc.	Health Care	2	<0.01%	−$6M	0 / 1	0 / 0
GPCR	Structure Therapeutics Inc.	Health Care	2 −1	<0.01%	−$29M	1 / 2	0 / 1
NVCR	Novocure Ltd	Health Care	2	<0.01%	+$494K	1 / 0	0 / 0
NGNE	Neurogene Inc.	Health Care	2	<0.01%	−$13M	0 / 2	0 / 0
LKFT	Galapagos NV	Health Care	2	<0.01%	+$7M	1 / 0	0 / 0
PEPG	Pepgen Inc.	Health Care	2 +1	<0.01%	+$2M	1 / 0	1 / 0
CMPS	Compass Pathways PLC	Health Care	2	<0.01%	−$601K	0 / 0	0 / 0
AXGN	Axogen Inc.	Health Care	2	<0.01%	$0	0 / 0	0 / 0
ENOV	Enovis Corporation	Health Care	2	<0.01%	−$9K	0 / 0	0 / 0
IVVD	Invivyd Inc.	Health Care	2	<0.01%	$0	0 / 0	0 / 0
HIMS	Hims & Hers Health Inc.	Health Care	2	<0.01%	+$55K	1 / 0	0 / 0
TMDX	Transmedics Group Inc.	Health Care	2 +1	<0.01%	+$11M	2 / 0	1 / 0
COGT	Cogent Biosciences Inc.	Health Care	2	<0.01%	−$4M	0 / 1	0 / 0
SPRY	Ars Pharmaceuticals Inc.	Health Care	2 +1	<0.01%	+$6M	1 / 1	1 / 0
RDNT	Radnet Inc.	Health Care	2	<0.01%	+$631K	1 / 0	0 / 0
EHC	Encompass Health Corp.	Health Care	2	<0.01%	−$213K	0 / 0	0 / 0
ARDT	Ardent Health Partners Inc. IPO or spin-off	Health Care	2 +2	<0.01%	+$6M	2 / 0	2 / 0
EDIT	Editas Medicine Inc.	Health Care	2	<0.01%	+$2M	1 / 0	0 / 0
STOK	Stoke Therapeutics Inc.	Health Care	2	<0.01%	$0	0 / 0	0 / 0
ANRO	Alto Neuroscience Inc.	Health Care	2 +1	<0.01%	+$2M	1 / 1	1 / 0
ALLO	Allogene Therapeutics Inc.	Health Care	2	<0.01%	+$1M	1 / 0	0 / 0
VNDA	Vanda Pharmaceuticals Inc.	Health Care	2	<0.01%	−$1M	0 / 1	0 / 0
MBX	Mbx Biosciences Inc. IPO or spin-off	Health Care	2 +2	<0.01%	+$1M	2 / 0	2 / 0
GRAL	Grail Inc.	Health Care	2 −1	<0.01%	−$6M	1 / 3	1 / 2
BCAX	Bicara Therapeutics Inc. IPO or spin-off	Health Care	2 +2	<0.01%	+$765K	2 / 0	2 / 0
MOH	Molina Healthcare Inc.	Health Care	1 −1	0.03%	+$135M	1 / 1	0 / 1
DOCS	Doximity Inc.	Health Care	1 −1	0.02%	+$65M	1 / 1	0 / 1
AGIO	Agios Pharmaceuticals Inc.	Health Care	1	0.02%	+$283K	0 / 0	0 / 0
RXRX	Recursion Pharmaceuticals Inc.	Health Care	1	0.02%	+$30M	1 / 0	0 / 0
HROW	Harrow Health Inc.	Health Care	1	0.01%	$0	0 / 0	0 / 0
RMD	Resmed Inc. IPO or spin-off	Health Care	1 +1	<0.01%	+$116M	1 / 0	1 / 0
WGS	Genedx Holdings Corp.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
WVE	Wave Life Sciences Ltd	Health Care	1 −1	<0.01%	+$17M	1 / 1	0 / 1
DNTH	Dianthus Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
QDEL	Quidelortho Corp.	Health Care	1 −1	<0.01%	−$52M	0 / 2	0 / 1
PHVS	Pharvaris N V	Health Care	1	<0.01%	$0	0 / 0	0 / 0
ALHC	Alignment Healthcare Inc.	Health Care	1	<0.01%	+$18M	1 / 0	0 / 0
CGON	Cg Oncology Inc.	Health Care	1	<0.01%	+$14M	1 / 0	0 / 0
TGTX	Tg Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
COR	Cencora Inc.	Health Care	1 −1	<0.01%	−$2M	0 / 1	0 / 1
ARCT	Arcturus Therapeutics Holdings	Health Care	1	<0.01%	+$3M	1 / 0	0 / 0
OCUL	Ocular Therapeutix Inc.	Health Care	1	<0.01%	−$2M	0 / 1	0 / 0
TFX	Teleflex Incorporated	Health Care	1	<0.01%	+$11M	1 / 0	0 / 0
USNA	Usana Health Sciences Inc.	Health Care	1	<0.01%	+$3M	1 / 0	0 / 0
ACAD	Acadia Pharmaceuticals Inc.	Health Care	1	<0.01%	+$2M	0 / 0	0 / 0
PSNL	Personalis Inc.	Health Care	1	<0.01%	+$4M	1 / 0	0 / 0
GH	Guardant Health Inc.	Health Care	1	<0.01%	+$24M	1 / 0	0 / 0
MYGN	Myriad Genetics Inc.	Health Care	1	<0.01%	−$68M	0 / 1	0 / 0
AVAH	Aveanna Healthcare Hldgs Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
PHAT	Phathom Pharmaceuticals Inc.	Health Care	1	<0.01%	+$3M	1 / 0	0 / 0
CERS	Cerus Corp.	Health Care	1	<0.01%	−$3M	0 / 1	0 / 0
LIVN	Livanova PLC	Health Care	1	<0.01%	−$2M	0 / 1	0 / 0
PRTA	Prothena Corp. PLC	Health Care	1	<0.01%	+$1M	0 / 0	0 / 0
INBX	Inhibrx Biosciences Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
STXS	Stereotaxis Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
RYTM	Rhythm Pharmaceuticals Inc.	Health Care	1	<0.01%	−$786K	0 / 0	0 / 0
ABSI	Absci Corp.	Health Care	1	<0.01%	+$3M	1 / 0	0 / 0
NMRA	Neumora Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
SRTA	Blade Air Mobility Inc.	Health Care	1	<0.01%	+$2M	1 / 0	0 / 0
ORKA	Oruka Therapeutics Inc. IPO or spin-off	Health Care	1 +1	<0.01%	+$19M	1 / 0	1 / 0
TAK	Takeda Pharmaceutical Co. Ltd	Health Care	1	<0.01%	−$1M	0 / 1	0 / 0
ATRC	Atricure Inc.	Health Care	1	<0.01%	+$70K	0 / 0	0 / 0
TERN	Terns Pharmaceuticals Inc.	Health Care	1	<0.01%	+$17M	1 / 1	1 / 1
MRVI	Maravai Lifesciences Hldgs I	Health Care	1 −1	<0.01%	−$6M	0 / 1	0 / 1
PGEN	Precigen Inc.	Health Care	1	<0.01%	−$224K	0 / 0	0 / 0
Enhabit	Enhabit Inc.	Health Care	1	<0.01%	+$443K	0 / 0	0 / 0
ETON	Eton Pharmaceuticals Inc.	Health Care	1	<0.01%	+$2M	1 / 0	0 / 0
AORT	Artivion Inc.	Health Care	1	<0.01%	+$631K	0 / 0	0 / 0
HSTM	Healthstream Inc.	Health Care	1	<0.01%	+$479K	0 / 0	0 / 0
TECX	Tectonic Therapeutic Inc.	Health Care	1	<0.01%	+$3M	1 / 0	0 / 0
CNTX	Context Therapeutics Inc.	Health Care	1	<0.01%	−$4K	0 / 0	0 / 0
EOLS	Evolus Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
PNTG	Pennant Group Inc.	Health Care	1	<0.01%	−$464K	0 / 0	0 / 0
VYGR	Voyager Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
CRMD	Cormedix Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
LFCR	Lifecore Biomedical Inc.	Health Care	1	<0.01%	+$62K	0 / 0	0 / 0
GUTS	Fractyl Health Inc.	Health Care	1	<0.01%	−$16K	0 / 0	0 / 0
Select Med	Select Med Hldgs Corp.	Health Care	1	<0.01%	+$638K	1 / 0	0 / 0
AHCO	Adapthealth Corp.	Health Care	1 −1	<0.01%	−$13M	0 / 1	0 / 1
APGE	Apogee Therapeutics Inc.	Health Care	1	<0.01%	−$20M	0 / 1	0 / 0
TNDM	Tandem Diabetes Care Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
RDY	Dr Reddy's Laboratories Ltd	Health Care	1	<0.01%	+$134K	0 / 0	0 / 0
Kalvista Pharmaceutic…	Kalvista Pharmaceuticals Inc.	Health Care	1	<0.01%	−$965K	0 / 1	0 / 0
COYA	Coya Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
KURA	Kura Oncology Inc.	Health Care	1	<0.01%	−$296K	0 / 0	0 / 0
CGEM	Cullinan Therapeutics Inc.	Health Care	1	<0.01%	−$19M	0 / 1	0 / 0
COLL	Collegium Pharmaceutical Inc.	Health Care	1 −2	<0.01%	−$6M	0 / 2	0 / 2
LZAGY	Lonza Group Adr	Health Care	1	<0.01%	−$68K	0 / 0	0 / 0
XOMA	Xoma Corp. Del	Health Care	1	<0.01%	$0	0 / 0	0 / 0
DMAC	Diamedica Therapeutics Inc.	Health Care	1	<0.01%	+$468K	1 / 0	0 / 0
SUPN	Supernus Pharmaceuticals, Inc.	Health Care	1	<0.01%	+$12K	0 / 0	0 / 0
CON	Concentra Group Holdings Par IPO or spin-off	Health Care	1 +1	<0.01%	+$6M	1 / 0	1 / 0
BCRX	Biocryst Pharmaceuticals Inc.	Health Care	1	<0.01%	−$285K	0 / 1	0 / 0
INFU	Infusystem Hldgs Inc.	Health Care	1	<0.01%	+$373K	1 / 0	0 / 0
SYRE	Spyre Therapeutics Inc.	Health Care	1 −2	<0.01%	−$25M	0 / 2	0 / 2
ALEC	Alector Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
RCUS	Arcus Biosciences Inc.	Health Care	1	<0.01%	+$54K	0 / 0	0 / 0
AMLX	Amylyx Pharmaceuticals Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
PODD	Insulet Corp.	Health Care	1 −1	<0.01%	−$63M	0 / 1	0 / 1
ZNTL	Zentalis Pharmaceuticals Inc. IPO or spin-off	Health Care	1 +1	<0.01%	+$4M	1 / 0	1 / 0
QURE	Uniqure NV IPO or spin-off	Health Care	1 +1	<0.01%	+$3M	1 / 0	1 / 0
LRMR	Larimar Therapeutics Inc.	Health Care	1	<0.01%	−$954K	0 / 1	0 / 0
HALO	Halozyme Therapeutics	Health Care	1	<0.01%	+$258K	1 / 0	0 / 0
ANGO	Angiodynamics Inc.	Health Care	1	<0.01%	+$1M	1 / 0	0 / 0
AQST	Aquestive Therapeutics Inc.	Health Care	1	<0.01%	+$297K	1 / 0	0 / 0
IPSC	Century Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
CERT	Certara Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
ATEC	Alphatec Hldgs Inc.	Health Care	1	<0.01%	+$2M	1 / 0	0 / 0
BWAY	Brainsway Ltd	Health Care	1	<0.01%	−$428K	0 / 1	0 / 0
RZLT	Rezolute Inc. IPO or spin-off	Health Care	1 +1	<0.01%	+$2M	1 / 0	1 / 0
Catalyst Pharmaceutic…	Catalyst Pharmaceuticals Inc.	Health Care	1	<0.01%	−$10M	0 / 1	0 / 0
BRKR	Bruker Corp. IPO or spin-off	Health Care	1 +1	<0.01%	+$2M	1 / 0	1 / 0
ARAY	Accuray Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
SNN	Smith & Nephew PLC IPO or spin-off	Health Care	1 +1	<0.01%	+$2M	1 / 0	1 / 0
ABCL	Abcellera Biologics Inc.	Health Care	1	<0.01%	+$2M	1 / 0	0 / 0
BIOA	Bioage Labs Inc. IPO or spin-off	Health Care	1 +1	<0.01%	+$2M	1 / 0	1 / 0
INGN	Inogen Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
Inmode	Inmode Ltd	Health Care	1	<0.01%	−$215K	0 / 1	0 / 0
AMN	Amn Healthcare Svcs Inc.	Health Care	1	<0.01%	−$719K	0 / 1	0 / 0
MLYS	Mineralys Therapeutics Inc.	Health Care	1	<0.01%	+$333K	1 / 0	0 / 0
AUTL	Autolus Therapeutics PLC	Health Care	1	<0.01%	+$508K	1 / 0	0 / 0
GMAB	Genmab A/S	Health Care	1	<0.01%	−$360K	0 / 1	0 / 0
PRQR	Proqr Therapeutics N V	Health Care	1	<0.01%	$0	0 / 0	0 / 0
TSHA	Taysha Gene Therapies Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
TVTX	Travere Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
Nano-X Imaging	Nano-X Imaging Ltd	Health Care	1	<0.01%	+$75K	1 / 0	0 / 0
CRBU	Caribou Biosciences Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
CVRX	Cvrx Inc.	Health Care	1	<0.01%	+$42K	0 / 0	0 / 0
ALDX	Aldeyra Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
VCEL	Vericel Corp.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
GANX	Gain Therapeutics Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0
IBIO	Ibio Inc.	Health Care	1	<0.01%	$0	0 / 0	0 / 0

How the numbers work

Same managers in both quarters

Changes compare only managers with a 13F in both 2024 Q2 and 2024 Q3: 133 this time. New in 2024 Q3: Rule One Partners.

Buying versus price

Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.

Who counts as a buyer or a seller

A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.

IPOs, spin-offs and mergers

A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.

Each manager once, or by dollars

By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.

Sectors

GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.

The combined book against SPY

Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.

What a 13F leaves out

Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.

The quarter at a glance